1.Faverly DR,
Hendriks JH,
Holland R.
Breast carcinomas of limited extent: frequency,
radiologic-pathologic characteristics,
and surgical margin requirements.
Cancer.
2001;91:647-59.
2.Houssami N,
Ciatto S,
Macaskill P,
Lord SJ,
Warren RM,
Dixon JM,
et al.
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer.
J Clin Oncol.
2008;26:3248-58.
3.Deurloo EE,
Peterse JL,
Rutgers EJ,
Besnard AP,
Muller SH,
Gilhuijs KG.
Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis.
Eur J Cancer.
2005;41:1393-401.
4.Lee JH,
Rosen EL,
Mankoff DA.
The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 1--overview,
detection,
and staging.
J Nucl Med.
2009;50(4):569-81.
5.Lee JH,
Rosen EL,
Mankoff DA.
The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy,
other indications,
and future directions.
J Nucl Med.
2009;50(5):738-48.
6.Jadvar H,
Alavi A,
Gambhir SS.
18F-FDG uptake in lung,
breast,
and colon cancers: molecular biology correlates and disease characterization.
J Nucl Med.
2009;50(11):1820-7.